The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease.
Youdim
M B
MB
Department of Pharmacology, Technion-Bruce Rappaport Faculty of Medicine, Haifa, Israel.
Ben-Shachar
D
D
Eshel
G
G
Finberg
J P
JP
Riederer
P
P
D000818:Animals; D003676:Deferoxamine / Q000494:pharmacology; D004292:Dominance, Cerebral / Q000187:drug effects / Q000502:physiology; D005293:Ferritins / Q000378:metabolism; D005609:Free Radicals; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D006878:Hydroxides / Q000378:metabolism; D017665:Hydroxyl Radical; D007276:Injections, Intraventricular; D007501:Iron / Q000378:metabolism / Q000633:toxicity*; D015227:Lipid Peroxidation / Q000187:drug effects / Q000502:physiology; D009569:Nitric Oxide / Q000378:metabolism / Q000633:toxicity*; D016627:Oxidopamine / Q000633:toxicity; D010300:Parkinson Disease / Q000209:etiology* / Q000503:physiopathology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000503:physiopathology; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects / Q000502:physiology; D013378:Substantia Nigra / Q000187:drug effects* / Q000503:physiopathology
D005609:Free Radicals; D006878:Hydroxides; D009569:Nitric Oxide; D017665:Hydroxyl Radical; D016627:Oxidopamine; D005293:Ferritins; D006861:Hydrogen Peroxide; D007501:Iron; D003676:Deferoxamine